NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000193

Registered date:12/09/2005

Randomized phase III trial comparing adjuvant oral UFT/LV to 5-FU/l-LV in stage III colorectal cancer (JCOG-0205-MF)

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedStage III colorectal cancer
Date of first enrollment2003/02/01
Target sample size1100
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)A: 5FU+l-leucovorin B: UFT+Leucovorin

Outcome(s)

Primary OutcomeDisease-free survival
Secondary OutcomeOverall survival, Rate of adverse event

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum75years-old
GenderMale and Female
Include criteria
Exclude criteria1) Active co-existing malignancy (synchronous or metachronous malignancy whose disease free period is within 5 years). Carcinoma in situ is eligible. 2) Severe postoperative complicatoins which do not resolve until registration. 3) There is following complicaion. insulin-controlling or uncontrollable diabetes mellitus, uncontrollable hypertension, myocardial infarction within six month or unstable angina pactoris, liver cirrhosis, interstitial pneumonia, pulmonary fibrosis, severe emphysema 4) Pregnant or breast-feeding woman. 5) Difficult to participate with the trial, having mentel disorder or psychiatric symptoms. 6) Judged to be inappropriate to register.

Related Information

Contact

public contact
Name Yasuhiro Shimada, MD
Address 5-1-1, Tsukiji, Chuo-ku, Tokyo, Japan 104-0045 Japan
Telephone
E-mail JCOG_sir@ml.jcog.jp
Affiliation JCOG0205 Coordinating Office Division of medical oncology, National Cancer Center Hospital
scientific contact
Name Yasuhiro Shimada, MD
Address 5-1-1, Tsukiji, Chuo-ku, Tokyo, Japan 104-0045 Japan
Telephone
E-mail
Affiliation National Cancer Center Hospital Division of medical oncology